insights_auto
Why is INDV up 2.96%?
Dive Deeperchevron_right
INDV:NASDAQ
Indivior Pharmaceuticals Inc
$36.88
arrow_upward
+2.96%(+1.06) 1D
$36.88
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$35.50
High
$36.96
Low
$35.43
Mkt. cap
4.35B
Avg. vol.
2.00M
Volume
8.00
P/E ratio
13.28
52-wk high
$42.81
52-wk low
$22.56
EPS
$2.78
Beta
1.03
Shares outstanding
118.03M
No. of employees
833
Open
$35.50
High
$36.96
Low
$35.43
Mkt. cap
4.35B
Avg. vol.
2.00M
Volume
8.00
P/E ratio
13.28
52-wk high
$42.81
52-wk low
$22.56
EPS
$2.78
Beta
1.03
Shares outstanding
118.03M
No. of employees
833
News stories
From web sources and news partners
PR Newswire
·
12 hours ago
ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH
AD HOC NEWS
·
15 hours ago
Indivior stock last trades at USD 36.88 on September 28, 2026
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com